Biopharmaceutical Scientists are integral to the development of new, life-saving medicines derived from biological sources. They combine expertise in biology, chemistry, and engineering to create innovative therapies, such as biologic drugs, vaccines, and gene therapies. These scientists work on the cutting edge of medical research, designing treatments that target complex diseases like cancer, autoimmune disorders, and infectious diseases. Their work involves identifying novel molecules, optimizing manufacturing processes, and ensuring that these therapies are safe, effective, and scalable. Biopharmaceutical scientists play a key role in improving the efficacy of treatments and expanding the scope of biologic therapies to address unmet medical needs.
Biopharmaceutical scientists collaborate with clinical researchers and regulatory agencies to guide their discoveries through clinical trials and regulatory approval. Their research helps pave the way for the development of targeted therapies, personalized medicine, and biologics that can address a variety of medical conditions more precisely than traditional chemical drugs. Through their dedication to scientific innovation, biopharmaceutical scientists are helping to revolutionize the field of medicine and improve the lives of countless patients. Their contributions are essential in shaping the future of healthcare, ensuring the development of effective treatments for a wide range of diseases.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia